Yield10 Bioscience, Inc. Common Stock
YTEN
YTEN was delisted on the 15th of May, 2024.
14 hedge funds and large institutions have $4.35M invested in Yield10 Bioscience, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
27% more funds holding
Funds holding: 11 → 14 (+3)
2% more capital invested
Capital invested by funds: $4.28M → $4.35M (+$69K)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$58.7K |
| 2 |
CWP
Concord Wealth Partners
Abingdon,
Virginia
|
+$15.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$13.6K |
| 4 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$7.23K |
| 5 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$3.92K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$249K |
| 2 |
CC
Cannell & Co
New York
|
-$59.8K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$34.8K |
| 4 |
BlackRock
New York
|
-$2.17K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ACM
1
AIGH Capital Management
Baltimore,
Maryland
| $1.82M | +$7.23K | +70 | +0.5% |
|
|
CC
2
Cannell & Co
New York
| $855K | -$59.8K | -579 | -8% |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $620K | – | – | – |
|
|
WVP
4
Worth Venture Partners
Fort Lee,
New Jersey
| $427K | +$3.92K | +38 | +1% |
|
|
5
BlackRock
New York
| $223K | -$2.17K | -21 | -1% |
|
|
6
Geode Capital Management
Boston,
Massachusetts
| $187K | -$34.8K | -337 | -19% |
|
|
BC
7
Birchview Capital
Burlington,
Vermont
| $99K | – | – | – |
|
|
8
Jane Street
New York
| $72K | +$58.7K | +569 | New |
|
|
CWP
9
Concord Wealth Partners
Abingdon,
Virginia
| $19K | +$15.1K | +146 | New |
|
|
10
UBS Group
Zurich,
Switzerland
| $17K | +$13.6K | +132 | New |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| $6K | +$2.79K | +27 | +142% |
|
|
RMC
12
Resources Management Corp
West Hartford,
Connecticut
| $1K | – | – | – |
|
|
IA
13
IFP Advisors
Tampa,
Florida
| $1K | +$103 | +1 | New |
|
|
14
Millennium Management
New York
| – | -$249K | -2,112 | Closed |
|
YTEN Hedge Fund Activity: Q1 2022 in Review
14 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q1 2022, worth a combined $4.35M — up 1.6% from $4.28M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new YTEN positions and 1 closed out — a net gain of 3 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $58.7K. The largest seller was Millennium Management, exiting entirely with an estimated $249K sold.
- 14 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q1 2022, up from 11 in Q4 2021.
- Funds reported $4.35M of Yield10 Bioscience, Inc. Common Stock stock for Q1 2022, up 1.6% quarter-over-quarter.
- 4 funds opened new Yield10 Bioscience, Inc. Common Stock positions in Q1 2022 and 1 closed out, a net change of +3 holders.
- The largest Yield10 Bioscience, Inc. Common Stock buyer in Q1 2022 was Jane Street, an estimated $58.7K added.
- The largest Yield10 Bioscience, Inc. Common Stock seller in Q1 2022 was Millennium Management, an estimated $249K sold.
Based on aggregated 13F filings for Q1 2022.